低剂量奥马珠单抗维持长期难治性慢性荨麻疹的缓解状态 - Suppr

Suppr

超能文献

Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria.

作者信息

Romano Ciro, Sellitto Ausilia, De Fanis Umberto, Esposito Gaetano, Arbo Paola, Giunta Riccardo, Lucivero Giacomo

出版信息

Ann Allergy Asthma Immunol. 2010 Jan;104(1):95-7. doi: 10.1016/j.anai.2009.11.017.

DOI:10.1016/j.anai.2009.11.017

PMID:20143654

Abstract

摘要

相似文献

Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria.

Ann Allergy Asthma Immunol. 2010 Jan;104(1):95-7. doi: 10.1016/j.anai.2009.11.017.

Effect of omalizumab on patients with chronic urticaria.

Ann Allergy Asthma Immunol. 2007 Aug;99(2):190-3. doi: 10.1016/S1081-1206(10)60644-8.

Omalizumab also successful in chronic urticaria.

J Allergy Clin Immunol. 2008 Mar;121(3):784; author reply 784-5. doi: 10.1016/j.jaci.2007.12.1174.

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.

Allergy. 2011 Feb;66(2):303-5. doi: 10.1111/j.1398-9995.2010.02472.x. Epub 2010 Sep 7.

Omalizumab is effective in nonautoimmune urticaria.

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.

Ann Allergy Asthma Immunol. 2013 Feb;110(2):113-7. doi: 10.1016/j.anai.2012.11.022. Epub 2012 Dec 20.

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.

J Allergy Clin Immunol. 2010 Sep;126(3):665-6. doi: 10.1016/j.jaci.2010.05.047. Epub 2010 Jul 31.

A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.

Ann Allergy Asthma Immunol. 2009 Dec;103(6):496-501. doi: 10.1016/S1081-1206(10)60266-9.

Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.

Allergol Immunopathol (Madr). 2015 Mar-Apr;43(2):168-73. doi: 10.1016/j.aller.2013.11.007. Epub 2014 Apr 14.

引用本文的文献

Anti-IgE for the Treatment of Chronic Urticaria.

Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.

Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.

Dermatol Ther (Heidelb). 2018 Jun;8(2):291-301. doi: 10.1007/s13555-018-0240-7. Epub 2018 May 16.

Omalizumab for chronic urticaria in Latin America.

World Allergy Organ J. 2016 Nov 23;9(1):36. doi: 10.1186/s40413-016-0127-y. eCollection 2016.

Role of biologics in intractable urticaria.

Biologics. 2015 Apr 13;9:25-33. doi: 10.2147/BTT.S63839. eCollection 2015.

Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.

Clin Drug Investig. 2015 Mar;35(3):159-68. doi: 10.1007/s40261-015-0267-9.

Treatment of chronic spontaneous urticaria.

Allergy Asthma Immunol Res. 2012 Nov;4(6):326-31. doi: 10.4168/aair.2012.4.6.326. Epub 2012 May 14.

Biologic agents in the treatment of urticaria.

Curr Allergy Asthma Rep. 2012 Aug;12(4):288-91. doi: 10.1007/s11882-012-0268-1.

Omalizumab for chronic urticaria: a case series and overview of the literature.

Case Rep Dermatol. 2012 Jan;4(1):19-26. doi: 10.1159/000336205. Epub 2012 Jan 30.

Omalizumab: Anti-IgE therapy in allergy.

Curr Allergy Asthma Rep. 2011 Apr;11(2):101-6. doi: 10.1007/s11882-010-0173-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria.

Ann Allergy Asthma Immunol. 2010 Jan;104(1):95-7. doi: 10.1016/j.anai.2009.11.017.

Effect of omalizumab on patients with chronic urticaria.

Ann Allergy Asthma Immunol. 2007 Aug;99(2):190-3. doi: 10.1016/S1081-1206(10)60644-8.

Omalizumab also successful in chronic urticaria.

J Allergy Clin Immunol. 2008 Mar;121(3):784; author reply 784-5. doi: 10.1016/j.jaci.2007.12.1174.

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.

Allergy. 2011 Feb;66(2):303-5. doi: 10.1111/j.1398-9995.2010.02472.x. Epub 2010 Sep 7.

Omalizumab is effective in nonautoimmune urticaria.

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.

Ann Allergy Asthma Immunol. 2013 Feb;110(2):113-7. doi: 10.1016/j.anai.2012.11.022. Epub 2012 Dec 20.

Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab.

J Allergy Clin Immunol. 2010 Sep;126(3):665-6. doi: 10.1016/j.jaci.2010.05.047. Epub 2010 Jul 31.

A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.

Ann Allergy Asthma Immunol. 2009 Dec;103(6):496-501. doi: 10.1016/S1081-1206(10)60266-9.

Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.

Allergol Immunopathol (Madr). 2015 Mar-Apr;43(2):168-73. doi: 10.1016/j.aller.2013.11.007. Epub 2014 Apr 14.

引用本文的文献

Anti-IgE for the Treatment of Chronic Urticaria.

Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.

Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.

Dermatol Ther (Heidelb). 2018 Jun;8(2):291-301. doi: 10.1007/s13555-018-0240-7. Epub 2018 May 16.

Omalizumab for chronic urticaria in Latin America.

World Allergy Organ J. 2016 Nov 23;9(1):36. doi: 10.1186/s40413-016-0127-y. eCollection 2016.

Role of biologics in intractable urticaria.

Biologics. 2015 Apr 13;9:25-33. doi: 10.2147/BTT.S63839. eCollection 2015.

Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.

Clin Drug Investig. 2015 Mar;35(3):159-68. doi: 10.1007/s40261-015-0267-9.

Treatment of chronic spontaneous urticaria.

Allergy Asthma Immunol Res. 2012 Nov;4(6):326-31. doi: 10.4168/aair.2012.4.6.326. Epub 2012 May 14.

Biologic agents in the treatment of urticaria.

Curr Allergy Asthma Rep. 2012 Aug;12(4):288-91. doi: 10.1007/s11882-012-0268-1.

Omalizumab for chronic urticaria: a case series and overview of the literature.

Case Rep Dermatol. 2012 Jan;4(1):19-26. doi: 10.1159/000336205. Epub 2012 Jan 30.

Omalizumab: Anti-IgE therapy in allergy.

Curr Allergy Asthma Rep. 2011 Apr;11(2):101-6. doi: 10.1007/s11882-010-0173-4.